Assistant Professor and Director, Pediatric Clinical and Translational Medicine Research Laboratory
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Bio for Stephanie Willette Waldrop, MD, MPH
Dr. Waldrop is a pediatrician with specialty training in pediatric obesity medicine and clinical nutrition. She is board certified in Pediatrics by the American Board of Pediatrics, Obesity Medicine by the American Board of Obesity Medicine, and as a Physician Nutrition Specialist by the National Board of Physician Nutrition Specialists. She is currently a K12 Louisiana Clinical and Translational Research Center Scholar (NIH/NIGMS U54 GM104940) and an Assistant Professor at Pennington Biomedical Research Center in the Division of Clinical Sciences at Pennington Biomedical Research Center where she serves as a clinical investigator on pediatric obesity pharmacotherapy trials and studies the intergenerational transmission of obesity in the context of epigenetic epidemiology with a focus on DNA methylation.
Her research interests include understanding the interactions of nutrition, maternal intrauterine exposures, and epigenetics on obesity and obesity co-morbidity risk in childhood. She aims to identify and assess the most optimal treatment strategies for children at risk of obesity and associated co-morbidities in the context of interactions between genetic and epigenetic predisposition, susceptibility conferred via intrauterine exposures, and their effects on infant and child growth and development. Her interests lie in understanding how the totality of these exposures and potential predictive biomarkers may enable precision interventions earlier in life and sustained throughout the life course.
Graduate Student Research Award Competition
Saturday, July 25, 2026
12:30 PM - 2:00 PM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Optimizing Nutrition for Early-Life Health: From Pregnancy to Early Childhood (Oral Session 18)
Monday, July 27, 2026
10:30 AM - 12:00 PM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Infant Formula Regulation and Nutritional Composition: Operation Stork Speed and Beyond
Tuesday, July 28, 2026
10:00 AM - 11:30 AM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Tuesday, July 28, 2026
10:00 AM - 10:15 AM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Tuesday, July 28, 2026
11:09 AM - 11:30 AM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.